ASCENTAGE PHARM. DL-,0001
[WKN: A2PUCQ | ISIN: KYG0519B1023]
Aktienkurse
5,900€ 0,85%
Echtzeit-Aktienkurs ASCENTAGE PHARM. DL-,0001
Bid: Ask:

Echtzeit-Chart der ASCENTAGE PHARM. DL-,0001 Aktie

ASCENTAGE PHARM. DL-,0001 Chart

Charttool öffnen

Börsenkurse ASCENTAGE PHARM. DL-,0001

Börse Frankfurt - - - - 5,900€ 0,85%
Börse Stuttgart - - - - 5,900€ 2,61%
Lang & Schwarz - - - - 5,900€ -2,88%

Profil der ASCENTAGE PHARM. DL-,0001 Aktie

Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.